NAUT
Nautilus Biotechnology
$2.44
−$0.80 (−24.69%)Oct 26, 2026
Key metrics
The numbers that frame NAUT today
- Market cap
- $310.50M
- Gross margin
- 92.1%
- EV / Sales
- 1,711.3
- ROIC
- -30.2%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.84
- 52wk High
- $4.31
Growth
Revenue and earnings trend for NAUT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NAUT
Is Nautilus Biotechnology a good buy?
No. Nautilus Biotechnology has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Nautilus Biotechnology is selling at a very high price.
What is the market capitalization of NAUT?
Nautilus Biotechnology's market capitalization is $310.50M.
What is the 52-week high for NAUT stock?
The 52-week high for Nautilus Biotechnology is $4.31. The current close of $2.44 is 43.4% below that high.
What is the 52-week low for NAUT stock?
The 52-week low for Nautilus Biotechnology is $0.84. The current close of $2.44 is 190.1% above that low.
Does NAUT stock pay dividends?
Nautilus Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NAUT?
Nautilus Biotechnology's Debt / Equity ratio is 0.21.